Shigella sonnei vaccine (AVANT Immunotherapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameShigella sonnei vaccine (AVANT Immunotherapeutics)
Drug Alias Namedysentery vaccine (AVANT)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelldex Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelldex Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDysentery, Bacillary

Other Information

ATC CodeN/A
Related LinksN/A